WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A REVIEW OF VACHADI GANA KALA BASTI AND HARIDRADI GANA KALA BASTI IN THE MANAGEMENT OF DYSLIPIDEMIA (SHONITA ABHISHYANDA)

Dr. Kritika Verma*, Dr. Nidhi Goswami, Dr. Shrimant G. Chavan

Abstract

Dyslipidemia, marked by deranged levels of Total Cholesterol, Triglycerides, LDL, VLDL and HDL, is a rapidly growing metabolic disorder associated with sedentary lifestyle, faulty dietary habits, obesity and insulin resistance, and is an important risk factor for cardiovascular disease. In Ayurveda this condition finds close correlation with Shonita Abhishyanda, a Viruddhaharajanya and Santarpanajanya Vyadhi arising from Excessive Abhishyandi guna intake progressive Kapha-Meda Dushti superimposed on Mandagni and Ama formation within the Raktavaha Srotas. Basti, described by Acharya Charaka as Ardha Chikitsa, is regarded as the principal Shodhana therapy for such Kapha-Meda disorders, through its Lekhana, Rukshana and Srotoshodhana actions. Lekhana type Basti in particular is indicated for conditions of excess Kapha and Medodhatu. This review compiles and compares two classical Kala Basti formulations described together in Ashtanga Hridaya, namely Vachadi Gana and Haridradi Gana, examining their composition, dose, method of preparation, mode of administration, and probable role in the management of Dyslipidemia. Vachadi Gana, composed of Vacha, Musta, Devadaru, Shunthi, Ativisha and Haritaki, carries a predominantly Deepana, Pachana, Lekhana and Kapha-Vata Shamaka profile, while Haridradi Gana, composed of Haridra, Daruharidra, Yashtimadhu, Prishniparni and Kutaja, combines Lekhana action with a stronger Kapha-Pitta Shamaka and hepato-supportive character. Administered as Kala Basti with alternating Niruha and Anuvasana Basti, both formulations appear to act through correction of Agni, reduction of Ama and Kapha-Meda, and Srotoshodhana of the Raktavaha Srotas. This review provides a conceptual and pharmacological basis supporting the use of these two Ganas as complementary Shodhana options in the management of Dyslipidemia.

Keywords: Ayurveda, Kala Basti, Vachadi Gana, Haridradi Gana, Dyslipidemia, Shonita Abhishyanda.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More